ghk-cu safety topical Peptide QUBIT GHK-Cu Copper Peptide Face

Kumar D, Kandl C, Hamilton CD, Shnayder Y, Tsue TT, Kakarala K, et al

Both BPC-157 and TB-500 are prohibited by the World Anti-Doping Agency

Degraded GHK-Cu = less active peptide than the label suggests

Nanoparticulate drug delivery systems have shown important advantages in stability and bioavailability, such as: protection of the drug from premature degradation and interaction with the physiological environment increased intracellular penetration increased solubility of insoluble drugs enhanced drug absorption [3] Smaller particles have larger surface area, which improves bioavailability The research has shown that smaller particles, preferably of 100 nm [4], significantly improve the bioavailability of the drug